Quadrant Capital Group LLC Accelerate Diagnostics, Inc Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022
SELL
$1.4 - $5.15 $168 - $618
-120 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$4.27 - $6.97 $512 - $836
120 New
120 $1,000
Q3 2021

Nov 12, 2021
SELL
$5.31 - $8.25 $3,159 - $4,908
-595 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$6.81 - $9.23 $4,051 - $5,491
595 New
595 $5,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $113M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email